期刊文献+

经皮冠状动脉成形术后冠心病患者血浆内皮素、血栓素B_2、6-酮-前列腺素F_(1α)水平变化的研究

Changes of plasma endothelin,thromboxame B_2 and 6-keto-PGF_(1α) in patients with coronary heart disease after PTCA
下载PDF
导出
摘要 目的探讨血管活性物质血浆内皮素(ET)、血栓素B_2(TXB_2)、6-酮-前列腺素F_(1α)(6-keto-PGF_(1α))与再狭窄的变化规律。方法用放射免疫法测定41例冠心病患者术前及术后30 min、1d、3 d的血浆ET、TXB_2、6 keto PGF_(1α)的浓度。结果PTCA术后血浆ET水平30 min较术前显著降低(P<0.05),术后1、3 d与术前差异无统计学意义(P>0.05);术后血浆TXB_2水平30 min、1 d及3d与术前比较差异无统计学意义(P>0.05),术后血浆6-keto PGF_(1α)水平30 min较术前显著降低(P<0.05),术后1、3 d与术前比较差异无统计学意义(P>0.05)。结论PTCA术后可引起冠状动脉循环ET、TXB_2、6-keto-PGF_(1α)的波动,研究这些血管活性物质的变化规律,对PTCA急性闭塞和远期再狭窄的预防有重要的意义。 Objective To explore the regularity of changes of plasma endothelin(ET),thromboxame B2 (TXB2) and 6-keto-prostaglandin Flo (6-keto-PGFlo) and restenosis after percutaneous transluminal angioplasty (PTCA) in patients with coronary heart disease. Methods Radioimmunoassay was applied to measuring plasma levels of ET,TXB2 and 6-keto-PGF1a at 0,30 rain, 1 day and 3 days after PTCA in 41 patients with coronary heart disease. Results The level of ET in the patients with coronary heart disease was significantly decreased in 30 minutes after PTCA (P〈0.05), but no significant difference was observed in 1 day and 3 days after PTCA (P〉0. 05). The level of plasma TXB2 has no statistical difference after PTCA in 30minutes, 1 day and 3 days (P〉0.05). The level of 6-keto-prostaglandin FI~ (6-keto-PGFlo) of the patients with coronary heart disease was significantly declined in 30 minutes after PTCA (P〈0.05), but no significant difference was observed in 1 day and 3 days after PTCA (P〉0. 05). Conclusion PTCA may lead to fluctuation of plasma levels of ET, TXB2 and 6-keto-PGF1a. The clarification of changing regularity of these vasoactive substances contributes to prevention of acute artery occlusion or restenosis after PTCA.
出处 《国际检验医学杂志》 CAS 2009年第9期843-844,847,共3页 International Journal of Laboratory Medicine
关键词 冠状动脉疾病 血管成形术 经腔 经皮冠状动脉 内皮缩血管肽类 6-酮-前列腺素F_1α Coronary disease Angioplasty, transluminal, percutaneous coronary Endothelins 6-Ketoprostaglandin F1 alpha
  • 相关文献

参考文献7

  • 1Cecena FA. Stenting the stent:alternative strategy for treating instent restenosis[J]. Cathet Cardiovasc Diagn, 1996,39 (4) : 377- 382. 被引量:1
  • 2Ware JA, Heistad DD. Platelet-endothelium interactions[J]. N Engl J Meal,1993,328(9) :628-635. 被引量:1
  • 3Harrison DG. Endothelial modulation of vascular tone: relevance to coronary angioplasty and restenosis[J].J Am Coll Cardiol, 1991,17(6 Suppl B) :71B- 76B. 被引量:1
  • 4Malatino LS,Grassi R, Stancanelli B, et al. Release of immunoreactive endothelin from the heart during pereutaneous transluminal coronary angioplasty[J]. Am Heart J, 1993,126 ( 1 ) : 700-702. 被引量:1
  • 5张宇,张向阳,马依彤,黄定,杨毅宁.冠状动脉内药物洗脱支架植入术后冠状静脉窦血中内皮素-1水平的变化[J].新疆医科大学学报,2006,29(4):306-308. 被引量:1
  • 6Hexum TD, Hoger C, Rivier JE, et al. Characterization of endo thelin by vascular endothelial cells[J]. Biochem Biophys Res Corn mun,1990,167(1) :294 300. 被引量:1
  • 7Hanke H, Strohschneider T, Oberhoff M, et al. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty[J]. Circ Res,1990,67(3): 651-659. 被引量:1

二级参考文献12

  • 1张社兵,刘君实,李金生.血管成形术后内膜增生的分子生物学机制[J].湘南学院学报(自然科学版),2004,6(3):64-68. 被引量:5
  • 2Cecena FA. Stenting stent: alternative strategy for treatin ginstent restenosis[J]. Cathet Cardiovasc Diagn, 1996, 39(4) :377. 被引量:1
  • 3Wang X, Douglas SA, Louden C, et al. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat[J]. Circ Res, 1996,78(2): 322-328. 被引量:1
  • 4Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells [J]. Circ Res, 1995, 76: 412-417. 被引量:1
  • 5Poon M, Marx SO, Gallo R, et al. Rapamycin inhibits vascular smooth muscle cell migration [J]. J Clin Invest, 1996, 98:2277-2283. 被引量:1
  • 6Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model[J]. Circulation, 2001, 104(10) : 1188-1193. 被引量:1
  • 7Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, doubleblind RAVEL (RAndomized study with the sirolimus eluting Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions) trial[J]. Circulation, 2002, 106(7):798-803. 被引量:1
  • 8Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size[J]. Circulation, 2002, 106(15): 1949-1956. 被引量:1
  • 9Hoffmann R, Guagliumi G, Musumeci G, et al. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials [J]. Catheter Cardiovasc Interv,2005, 66(4): 499-506. 被引量:1
  • 10Mcclellan G, Wersberg A, Rose D, et al. Endothelial cell storage and release of endothelin as a cardioregulatery mechanism [J]. Circ Res, 1994, 75(1): 85-96. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部